ID   G2LWE9_9XANT            Unreviewed;       311 AA.
AC   G2LWE9;
DT   16-NOV-2011, integrated into UniProtKB/TrEMBL.
DT   16-NOV-2011, sequence version 1.
DT   29-MAY-2013, entry version 13.
DE   SubName: Full=Cytochrome O ubiquinol oxidase subunit II;
GN   Name=cyoA; ORFNames=XACM_1234;
OS   Xanthomonas axonopodis pv. citrumelo F1.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Xanthomonadales;
OC   Xanthomonadaceae; Xanthomonas.
OX   NCBI_TaxID=981368;
RN   [1]
RP   NUCLEOTIDE SEQUENCE.
RC   STRAIN=F1;
RX   PubMed=21908674; DOI=10.1128/JB.05777-11;
RA   Jalan N., Aritua V., Kumar D., Yu F., Jones J.B., Graham J.H.,
RA   Setubal J.C., Wang N.;
RT   "Comparative Genomic Analysis of Xanthomonas axonopodis pv. citrumelo
RT   F1, Which Causes Citrus Bacterial Spot Disease, and Related Strains
RT   Provides Insights into Virulence and Host Specificity.";
RL   J. Bacteriol. 193:6342-6357(2011).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CP002914; AEO41518.1; -; Genomic_DNA.
DR   RefSeq; YP_004850816.1; NC_016010.1.
DR   ProteinModelPortal; G2LWE9; -.
DR   SMR; G2LWE9; 125-284.
DR   EnsemblBacteria; AEO41518; AEO41518; XACM_1234.
DR   GeneID; 11131551; -.
DR   KEGG; xax:XACM_1234; -.
DR   KO; K02297; -.
DR   BioCyc; XALF981368:GH9H-1234-MONOMER; -.
DR   GO; GO:0016021; C:integral to membrane; IEA:InterPro.
DR   GO; GO:0005507; F:copper ion binding; IEA:InterPro.
DR   GO; GO:0009486; F:cytochrome bo3 ubiquinol oxidase activity; IEA:InterPro.
DR   GO; GO:0008827; F:cytochrome o ubiquinol oxidase activity; IEA:InterPro.
DR   GO; GO:0004129; F:cytochrome-c oxidase activity; IEA:InterPro.
DR   GO; GO:0022900; P:electron transport chain; IEA:InterPro.
DR   Gene3D; 1.10.287.90; -; 1.
DR   Gene3D; 2.60.40.420; -; 1.
DR   InterPro; IPR012141; Bo-type_Ubol_Oxase_su_II.
DR   InterPro; IPR010514; COX_ARM.
DR   InterPro; IPR008972; Cupredoxin.
DR   InterPro; IPR002429; Cyt_c_oxidase_su2_C.
DR   InterPro; IPR011759; Cyt_c_oxidase_su2_TM_dom.
DR   InterPro; IPR006333; Cyt_o_ubiquinol_oxidase_su2.
DR   Pfam; PF00116; COX2; 1.
DR   Pfam; PF06481; COX_ARM; 1.
DR   PIRSF; PIRSF000292; Ubi_od_II; 1.
DR   SUPFAM; SSF49503; Cupredoxin; 1.
DR   SUPFAM; SSF81464; Cyt_c_oxidase_II-like_TM; 1.
DR   TIGRFAMs; TIGR01433; CyoA; 1.
DR   PROSITE; PS50857; COX2_CUA; 1.
DR   PROSITE; PS50999; COX2_TM; 1.
PE   4: Predicted;
SQ   SEQUENCE   311 AA;  34472 MW;  8D7057A5A753D364 CRC64;
     MIPLKQLGRL LRPGLMLPFL LLAGCNSAIL NPKGQIGHDE KQLLITSVVL MLIVVIPVIV
     MTIAFAWKYR ASNTKARYEP DWSHSTAIEV VVWSIPCVII LVLAVLTWRS SHALDPYRPL
     DSDVKPINIE AVSLDWKWMF IYPDQNIATV NEIAFPVHTP LNFKITSDTV MNSFFIPHLG
     TMIYAMAGME TKLHLVANEP GEYFGLSTNY SGHGFSKMSF KAHAVDQAGF EAWVAKVKAS
     PTALNAAEYQ VLAANRNDKE QYPVTYYSSV QDGMFRSLVD KYMNGPGHSK GHGDHQASAT
     EPVAMCTSGD K
//